VBI Vaccines Inc. 14,000,000 Common Shares (no par value per share) Underwriting AgreementVBI Vaccines Inc/Bc • October 27th, 2017 • Pharmaceutical preparations • New York
Company FiledOctober 27th, 2017 Industry JurisdictionVBI Vaccines Inc., a company incorporated under the Business Corporations Act (British Columbia) (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 14,000,000 common shares, no par value per share (the “Shares”). The 14,000,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,100,000 Shares as provided in Section 2. The additional 2,100,000 Shares that may be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” BMO Capital Markets Corp. (“BMOCM”) and Canaccord Genuity Inc. (“Canaccord”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering a
SUBSCRIPTION AGREEMENTSubscription Agreement • October 27th, 2017 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
Contract Type FiledOctober 27th, 2017 Company Industry JurisdictionThis Subscription Agreement (this “Subscription”) is dated as of October 26, 2017, by and between VBI Vaccines Inc., a company incorporated under the laws of British Columbia, Canada (the “Company”), and each investor identified on the signature page hereto (each, including its successors and assigns, a “Investor” and collectively the “Investors”).